Paul L Berns

Paul Berns, our Chairman, has served as a member of our board since 2012. Paul Berns is a self-employed consultant to the pharmaceutical industry.From March 2006 to August 2012 Paul Berns served as President and Chief Executive Officer, and member of the Board of Directors, of Allos Therapeutics, Inc., which was acquired by Spectrum Pharmaceuticals, Inc. in August 2012. From July 2005 to March 2006 .Paul Berns was a self-employed consultant to the pharmaceutical industry.

From June 2002 to July 2005, Paul Berns was president, Chief Executive Officer and a director of Bone Care International, Inc., a specialty pharmaceutical company that was acquired by Genzyme Corporation in 2005. From 2001 to 2002, Paul Berns served as Vice President and General Manager of the Immunology, Oncology and Pain Therapeutics business unit of Abbott Laboratories.

From 2000 to 2001, he served as Vice President, Marketing of BASF Pharmaceuticals/Knoll and from 1990 to 2000, Paul Berns held various positions, including senior management roles, at Bristol-Myers Squibb Company.Paul Berns has been a director of Anacor Pharmaceuticals, Inc.since June 2012, Jazz Pharmaceuticals, PLC since June 2010, and of XenoPort, Inc.since 2005. Paul Berns received a B.S. in Economics from the University of Wisconsin.

Paul L Berns is the Chief Executive Officer & President at Anacor Pharmaceutical, based in United States, North America. With a background in Biotechnology, Paul L Berns has a rich history of leadership and innovation. Paul L Berns studied BS Economics @ University of Wisconsin-Madison. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.